TOPICAL: Randomized phase III trial of erlotinib compared with placebo in chemotherapy-naive patients with advanced non-small cell lung cancer (NSCLC) and unsuitable for first-line chemotherapy.
2010 ◽
Vol 28
(15_suppl)
◽
pp. 7504-7504
◽
Keyword(s):
Keyword(s):
Keyword(s):
2007 ◽
Vol 2
(8)
◽
pp. S693-S694
Keyword(s):
Keyword(s):
2008 ◽
Vol 26
(15_suppl)
◽
pp. 8016-8016
◽
Keyword(s):
2011 ◽
Vol 29
(15_suppl)
◽
pp. 7551-7551
◽
Keyword(s):
2013 ◽
Vol 31
(15_suppl)
◽
pp. 7507-7507
◽
Keyword(s):
2015 ◽
Vol 33
(15_suppl)
◽
pp. 8049-8049
Keyword(s):
2016 ◽
Vol 34
(15_suppl)
◽
pp. TPS8578-TPS8578
◽
Keyword(s):
Keyword(s):